id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0022-0008,FDA,FDA-2010-E-0022,"U.S. Patent and Trademark Office to Theravance, Inc. - Letter",Other,Letter(s),2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2013-05-07T18:46:21Z,,0,0,09000064812bcc28